1:chemotherapy
Sponsors
People's Hospital of Peking University, Sun Yat-sen University Cancer Center, Shanghai Tenth People's Hospital, Institute of Hematology Blood Disease Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, West China Hospital, Sichuan University
Conditions
Bladder cancerCancerChildren with haematological diseasescolorectal cancerlymphoplasmacytic lymphoma / Waldenstrom macroglobulinemiamantle cell lymphomatriple negative breast cancer
Early Phase 1
Phase 3
A prospective multicentre phase III trial for new diagnosed younger (age<65 years) mantle cell lymphoma in China
Active, not recruitingChiCTR-OPC-15007260
Start: 2016-01-01Updated: 2017-04-18
Randomized prospective investigation of recurrence and progression between intra-artery chemotherapy and intravesical treatment for T1G3 bladder cancer
Active, not recruitingChiCTR-IIR-16007877
Start: 2016-02-24Updated: 2017-04-18
The efficientcy of thalidomide plus cyclophosphamide and dexamethasone following by thalidomide and prednisone maintaince therapy for the newly diagnosed Waldenstr?m macroglobulinemia - a Prospective Multicentre Phase III Trial from China
RecruitingChiCTR-OIC-16008402
Start: 2016-05-01Updated: 2017-04-18
Unknown Phase
The clinical research of intensive chemotherapy to triple negative breast cancer
RecruitingChiCTR-OOS-14005503
Start: 2014-10-01Updated: 2017-04-18
The role of Chinese medicine BDL in chemotherapy related inflammation, a clinical research
Active, not recruitingChiCTR-IOR-16009728
Start: 2017-01-01Updated: 2017-04-18
Clinical study on regulating immune cells by Yiqi Huayu Jiedu to reduce the risk of recurrence and metastasis of colorectal cancer after operation
RecruitingITMCTR2025000268
Start: 2024-08-08Updated: 2025-03-03